Guidelines for multi-model comparisons of the impact of infectious disease interventions

Model Comparisons of the Effectiveness and Cost-effectiveness of Vaccination: A Systematic Review of the Literature

(2018) Mélanie Drolet et al.   VALUE IN HEALTH

An ensemble approach to predicting the impact of vaccination on rotavirus disease in Niger

(2017) Jaewoo Park et al.   VACCINE

Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework

(2017) Morgan E. Smith et al.   Epidemics

Learning from multi-model comparisons: Collaboration leads to insights, but limitations remain

(2017) T.D. Hollingsworth et al.   Epidemics

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

(2016) Melissa A Penny et al.   LANCET

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

(2016) Stefan Flasche et al.   PLOS MEDICINE

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models

(2016) Rein M G J Houben et al.   Lancet Global Health

What makes an academic paper useful for health policy?

(2015) Christopher J. M. Whitty   BMC Medicine

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community

(2015) Bernhard Ultsch et al.   PHARMACOECONOMICS

Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios

(2014) Martine Hoogendoorn et al.   VALUE IN HEALTH

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

(2013) D. Husereau et al.   BMJ-British Medical Journal

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

(2013) Jeffrey W Eaton et al.   Lancet Global Health

Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

(2012) David M. Eddy et al.   VALUE IN HEALTH

HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa

(2012) Jeffrey W. Eaton et al.   PLOS MEDICINE

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

(2011) Maarten J Postma et al.   BMC Medicine

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools

(2011) Nathorn Chaiyakunapruk et al.   BMC Medicine

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal

(2011) Raymond Hutubessy et al.   BMC Medicine

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

(2011) Mark Jit et al.   BMC Medicine

Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data

(2011) C. L. Althaus et al.   Journal of the Royal Society Interface

Modelling the Epidemiology of Infectious Diseases for Decision Analysis

(2011) Mark Jit et al.   PHARMACOECONOMICS

Male Circumcision for HIV Prevention in High HIV Prevalence Settings: What Can Mathematical Modelling Contribute to Informed Decision Making?

(2009)   PLOS MEDICINE

Modeling targeted layered containment of an influenza pandemic in the United States

(2008) M. E. Halloran et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Modeling Cervical Cancer Prevention in Developed Countries

(2008) Jane J. Kim et al.   VACCINE